---
title: "Ortin Global Ltd (ORTINGLOBE) — Share Price, Financials & Analysis"
symbol: "ORTINGLOBE"
company: "Ortin Global Ltd"
canonical: "https://tapetide.com/stocks/ORTINGLOBE"
isin: "INE749B01020"
nse_symbol: "ORTINGLOBE"
bse_code: "539287"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 13.8
generated_at: "2026-09-13T18:27:43.609Z"
---

# Ortin Global Ltd (ORTINGLOBE)

Canonical page: https://tapetide.com/stocks/ORTINGLOBE

## Company

- **NSE Symbol:** ORTINGLOBE
- **BSE Code:** 539287
- **ISIN:** INE749B01020
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2021-03-30
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** ortinlabsindia.com

## About

Incorporated in 1986, Ortin Laboratories Ltd           manufactures pharmaceutical formulations.[1]

## Latest Price

- **Price:** ₹17.09
- **Change:** +0.79 (+4.85%)
- **Open:** ₹16.7
- **Day High:** ₹17.11
- **Day Low:** ₹15.81
- **Previous Close:** ₹16.3
- **Volume:** 30391
- **As Of:** 2026-09-11T09:43:51+00:00

## Key Fundamentals

Observed at 2026-09-11T04:40:50.334158Z.

- **Market Cap:** ₹13.8 Cr
- **Classification:** Microcap
- **P/E (reported):** -14.5
- **EPS (TTM):** ₹-1.1
- **Book Value:** ₹1.53
- **Price to Book:** 10.53
- **Dividend Yield:** 0%
- **ROE:** -42.8%
- **ROCE:** -37.48%
- **Debt to Equity:** 0.81
- **Revenue (yearly):** ₹0.1 Cr
- **Net Income:** ₹-0.72 Cr
- **EBITDA:** ₹-1.04 Cr
- **52-Week High:** ₹21.3
- **52-Week Low:** ₹10.66
- **RSI (14):** 57.66

## Tapetide Score

- **Score:** 37 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Flat
- **Percentile:** 8.7 (of 4473 scored stocks)
- **Confidence:** 91%
- **Data coverage:** 81%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 14.52 | 9% |
| growth | 79.72 | 9% |
| momentum | 54.03 | 12% |
| ownership | 52.55 | 24% |
| quality | 26.37 | 22% |
| valuation | 29.55 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Debtor days have improved from 260 to 178 days.

### Weaknesses

- Stock is trading at 11.2 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -45.0% over past five years.
- Promoter holding is low: 1.23%
- Company has a low return on equity of -72.7% over last 3 years.
- Contingent liabilities of Rs.24.3 Cr.
- Company might be capitalizing the interest cost
- Company has high debtors of 178 days.
- Promoter holding has decreased over last 3 years: -6.13%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 91.44% | -64% | -102.27% |
| ebitda margin growth | 77.42% | — | — | — |
| net income growth | 121.05% | -10% | -91% | 80% |
| revenue growth | -25% | -75% | -59% | -45% |
| roce | — | -73.7% | — | -33.66% |
| roe | — | -84.97% | -109.47% | -613.81% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.27 | 0.14 | 0.3 | 0.21 | 0.05 | 0.03 | 0.09 | 0.08 | 0.01 | 0.01 | 0.3 | 0.01 |
| Expenses | 1.17 | 2.74 | 3.35 | 0.31 | 0.5 | 0.16 | 0.25 | 0.24 | 0.51 | 0.06 | 0.31 | 0.34 |
| Operating Profit | -0.9 | -2.6 | -3.05 | -0.1 | -0.45 | -0.13 | -0.16 | -0.16 | -0.5 | -0.05 | -0.01 | -0.33 |
| OPM % | -333.33 | -1857.14 | -1016.67 | -47.62 | -900 | -433.33 | -177.78 | -200 | -5000 | -500 | -3.33 | -3300 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0.15 | 0.14 | 0.08 | 0 | 0.02 | -0.01 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.06 | 0.06 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -1.11 | -2.8 | -3.18 | -0.1 | -0.47 | -0.1 | -0.16 | -0.16 | -0.5 | -0.05 | -0.01 | -0.33 |
| Tax % | 1.8 | -0.71 | 30.19 | 0 | 0 | 10 | 0 | 6.25 | 0 | 0 | 0 | 0 |
| Net Profit | -1.12 | -2.79 | -4.14 | -0.1 | -0.47 | -0.11 | -0.16 | -0.18 | -0.5 | -0.05 | -0.01 | -0.34 |
| EPS in Rs | -1.38 | -3.43 | -5.09 | -0.12 | -0.58 | -0.14 | -0.2 | -0.22 | -0.61 | -0.06 | -0.01 | -0.42 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 79.63 | 167.51 | 197.36 | 8.16 | 8.23 | 6 | 2.01 | 0.34 | 0.41 | 0.33 |
| Expenses | 74.22 | 160.83 | 191.66 | 6.92 | 7.85 | 5.47 | 6.4 | 1.23 | 1.13 | 1.22 |
| Operating Profit | 5.41 | 6.68 | 5.7 | 1.24 | 0.38 | 0.53 | -4.39 | -0.89 | -0.72 | -0.89 |
| OPM % | 6.79 | 3.99 | 2.89 | 15.2 | 4.62 | 8.83 | -218.41 | -261.76 | -175.61 | -269.7 |
| Other Income | 0.45 | 0.13 | 0.18 | 0.05 | 0.19 | 0.01 | -1.98 | 0.06 | 0 | 0 |
| Interest | 3.49 | 3.22 | 3.21 | 0.87 | 0.81 | 0.4 | 0.48 | 0 | 0 | 0 |
| Depreciation | 1.69 | 1.75 | 1.96 | 0.29 | 0.29 | 0.25 | 0.23 | 0.01 | 0 | 0 |
| Profit before tax | 0.68 | 1.84 | 0.71 | 0.13 | -0.53 | -0.11 | -7.08 | -0.84 | -0.72 | -0.89 |
| Tax % | 0 | 30.43 | 181.69 | -623.08 | -24.53 | -18.18 | 13.56 | 1.19 | 2.78 | — |
| Net Profit | 0.68 | 1.28 | -0.56 | 0.95 | -0.4 | -0.09 | -8.04 | -0.85 | -0.74 | -0.9 |
| EPS in Rs | 0.4 | 0.76 | -0.33 | 1.17 | -0.49 | -0.11 | -9.89 | -1.05 | -0.91 | -1.1 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 16.94 | 16.94 | 16.94 | 16.94 | 8.13 | 8.13 | 8.13 | 8.13 | 8.13 | 8.13 |
| Reserves | 6.46 | 7.14 | 8.15 | 6.88 | 3.22 | 2.83 | 2.73 | -5.31 | -6.15 | -6.89 |
| Borrowings | 17.34 | 17.34 | 19.47 | 19.57 | 6.94 | 6.14 | 6.45 | 1.8 | 0.25 | 1.01 |
| Other Liabilities | 20.79 | 32.24 | 60.53 | 73.13 | 2.97 | 3.61 | 3.89 | 2.05 | 1.55 | 2.4 |
| Total Liabilities | 61.53 | 73.66 | 105.09 | 116.52 | 21.26 | 20.71 | 21.2 | 6.67 | 3.78 | 4.65 |
| Fixed Assets | 20.69 | 20.03 | 21.29 | 22.45 | 14.38 | 14.21 | 13.96 | 0.01 | 0 | 0.01 |
| CWIP | 0.35 | 0.4 | 0.53 | 0.43 | 0.43 | 0.43 | 0.43 | 0 | 0 | 0 |
| Investments | 0.07 | 0.08 | 0.08 | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 40.42 | 53.15 | 83.19 | 93.57 | 6.45 | 6.07 | 6.81 | 6.66 | 3.78 | 4.64 |
| Total Assets | 61.53 | 73.66 | 105.09 | 116.52 | 21.26 | 20.71 | 21.2 | 6.67 | 3.78 | 4.65 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 1.94 | 1.56 | 6.52 | 3.3 | 18.03 | 2.15 | -0.25 | -4.79 | -0.41 | -0.56 |
| Cash from Investing Activity | -1.26 | -0.9 | -3.27 | -3.09 | 0.07 | -0.13 | 0.01 | 12 | 0 | 0.04 |
| Cash from Financing Activity | -0.82 | 0.07 | -2.89 | -1.33 | -9.86 | -0.48 | 0.9 | -3.49 | 0.33 | 0.75 |
| Net Cash Flow | -0.14 | 0.73 | 0.37 | -1.12 | 8.25 | 1.55 | 0.66 | 3.72 | -0.09 | 0.23 |
| Free Cash Flow | 0.83 | 0.77 | 3.38 | 0.28 | 18.03 | 2.02 | -0.24 | 7.21 | -0.41 | -0.52 |
| CFO/OP | 47 | 40 | 104 | 72 | 1454 | 566 | -47 | 80 | 46 | 78 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 90.35 | 100.15 | 82.43 | 68.71 | 174.9 | 143.69 | 208.05 | 321.42 | 279.12 | 178.05 |
| Inventory Days | 158.21 | 152.21 | 100.07 | 117.8 | 169.1 | 136.29 | 279.94 | 4.92 | 34.76 | 0 |
| Days Payable | 108.1 | 143.09 | 145.12 | 155.8 | 123.82 | 61.88 | 166.89 | 7.87 | 69.52 | — |
| Cash Conversion Cycle | 140.45 | 109.28 | 37.38 | 30.7 | 220.17 | 218.1 | 321.1 | 318.47 | 244.36 | 178.05 |
| Working Capital Days | 37.29 | 41.48 | 16.82 | 11.24 | -87.22 | -109.1 | -43.19 | 357.74 | 1524.41 | 730 |
| ROCE % | 9.57 | 9.44 | 11.77 | 8.94 | 3.24 | 1.58 | 1.8 | -40.58 | -25.11 | -32.14 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 7.37% | 7.36% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% |
| FIIs | 0% | 0% | 0% | 6.25% | 6.25% | 6.25% | 6.53% | 6.53% | 1.68% | 1.68% | 1.68% | 1.8% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 86.94% | 86.06% | 92.04% | 85.84% | 83.55% | 84.26% | 85.32% | 85.66% | 90.85% | 91.01% | 91.18% | 90.87% |
| Others | 5.69% | 6.58% | 6.73% | 6.68% | 8.97% | 8.26% | 6.92% | 6.58% | 6.23% | 6.08% | 5.9% | 6.1% |
| No. of Shareholders | 11836 | 12314 | 12192 | 11952 | 12165 | 12094 | 12144 | 12034 | 12060 | 11834 | 11452 | 11383 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 4 / 3

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 15.76 | Buy |
| EMA (10) | 15.91 | Buy |
| SMA (20) | 15.62 | Buy |
| EMA (20) | 15.7 | Buy |
| SMA (50) | 15.53 | Buy |
| EMA (50) | 15.67 | Buy |
| SMA (100) | 15.8 | Buy |
| EMA (100) | 15.59 | Buy |
| SMA (200) | 15.14 | Buy |
| EMA (200) | 15.05 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 63.52 | Neutral |
| MACD (12,26,9) | 0.19 | Buy |
| Stochastic (14,3,3) | 84.74 | Sell |
| ADX (14) | 13.19 | Neutral |
| Williams %R (14) | -0.8 | Sell |
| ATR (14) | 0.91 | High Volatility |
| ROC (12) | 11.34 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 59.95 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-08 | [Resignation Letter](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c3bedd8-d469-4284-b083-7e6cfbdd57d9.pdf) |
| 2026-09-08 | [Notice Of AGM For The FY 2025-26 Scheduled To Be Held On 30.09.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=601943b4-16f7-4139-9711-c4c893e2c311.pdf) |
| 2026-09-08 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a80126f-c969-4816-9872-eb026538fd8d.pdf) |
| 2026-09-07 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc9b3c59-c04b-4875-93c4-e4b1c1dbb629.pdf) |
| 2026-09-07 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=918ecde5-1ece-4343-a2aa-9c1d63fd868a.pdf) |
| 2026-08-14 | [Board Meeting Outcome for Outcome Of Board Meeting Held On 14.08.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be310768-047e-4a97-81b0-d7d2982e1d76.pdf) |
| 2026-08-07 | [Board Meeting Intimation for Meeting To Be Held On 14.08.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da548718-5f14-4f21-99bf-848b97a0a95f.pdf) |
| 2026-07-11 | [Post-Offer Advertisement](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=756A11B0-7CB4-43BC-9484-1C2929633204-090848.pdf) |
| 2026-07-11 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f97fa227-b9a6-44a3-aac4-5a2adbf0e07d.pdf) |
| 2026-06-24 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7f1645a-4336-4ef7-bc7b-e2b3f964496b.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Unaudited Financial Results For The Quarter Ended 30.06.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a64d0d3-412c-470b-81da-4ea746343e51.pdf) |
| 2026-05-30 | [Audited Financial Results Along With Audit Report For The Quarter And Year Ended 31.03.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fbbd283e-f194-41de-806b-efa3d99df2f6.pdf) |
| 2026-02-14 | [Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3241bbaf-5104-4c2d-b8ff-f0585de8d103.pdf) |
| 2025-11-14 | [Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=348c3646-7989-473b-b7e7-e4cb451d31d7.pdf) |
| 2025-08-14 | [Unaudited Financial Results For The Quarter Ended 30.06.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f531087c-3af6-4d44-9d86-2669d9edfa9a.pdf) |
| 2025-05-26 | [Audited Financials Of The Company For The Quarter And Year Ended On 31-03-2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27d4af58-61b1-44aa-8521-51ac2370c0d6.pdf) |
| 2025-02-12 | [UN-AUDITED FINANCIAL RESULTS FOR QUARTER ENDED 31-12-2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=487ef18d-865b-47e4-b6d0-788ff45b4acd.pdf) |
| 2024-11-13 | [Un-Audited Results For The Quarter Ended On 30-09-2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db783b0e-835d-4ba4-b2e1-50f69d1bd73f.pdf) |
| 2024-08-13 | [Un-Audited Financial Results For The Quarter Ended 30-06-2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b070263e-66ab-4612-a185-1f74c0d27699.pdf) |
| 2024-05-30 | [Audited Financial Results For The Quarter And Financial Year Ended 31.03.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d21f4f58-c4c6-4147-bb8f-aefa7c47f19f.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 6 May - Ortin Global confirms it is not a Large Corporate for FY 2026-27. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 6 May - Ortin Global confirms it is not a Large Corporate for FY 2026-27.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/f1d8b0a6-72ca-4d2b-bdf6-7348c780b450.pdf) |
| 30 Apr - Ortin Global says it is not a Large Corporate for FY2025-26; debt borrowing nil. | [Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 30 Apr - Ortin Global says it is not a Large Corporate for FY2025-26; debt borrowing nil.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3bc04988-fa41-4fdc-b613-801553152442.pdf) |
| 30 Apr - Ortin Global says it is not a Large Corporate for FY2025-26; debt borrowing nil. | [Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 30 Apr - Ortin Global says it is not a Large Corporate for FY2025-26; debt borrowing nil.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/3bc04988-fa41-4fdc-b613-801553152442.pdf) |
| 27 Feb - Newspaper page containing multiple corporate notices; unreadable single announcement. | [Corrigendum to Detailed Public Statement 27 Feb - Newspaper page containing multiple corporate notices; unreadable single announcement.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9F97B92A-C8C3-4107-8232-008D4DC7E427-181425.pdf) |
| 26 Feb - Rarever Financial Advisors Pvt. Ltd. ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer for the attention of the … | [Draft Letter of Offer 26 Feb - Rarever Financial Advisors Pvt. Ltd. ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer for the attention of the …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1FC9818F-9303-4FBA-937B-A9B940C5CD34-081149.pdf) |
| 26 Feb - Disclosure under Regulation 29(1) & 29(2) of SEBI (SAST) Regulations, 2011 for Suresh Gadalay & PACs | [Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011 26 Feb - Disclosure under Regulation 29(1) & 29(2) of SEBI (SAST) Regulations, 2011 for Suresh Gadalay & PACs](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0329A96A_E2D2_4440_99ED_40DD7B771604_084608.pdf) |
| 18 Feb - Parveen Satija to acquire 21,14,162 shares (26%) at ₹14.65; offer consideration ₹3.09 Crore; tender Apr 10–24, 2026. | [Detailed Public Statement 18 Feb - Parveen Satija to acquire 21,14,162 shares (26%) at ₹14.65; offer consideration ₹3.09 Crore; tender Apr 10–24, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/DDDDD898-D122-464A-A975-14BDCFF35FC1-085401.pdf) |
| 17 Feb - Newspaper Publication of Unaudited Financial Results for the quarter and nine months ended 31.12.2025 | [Announcement under Regulation 30 (LODR)-Newspaper Publication 17 Feb - Newspaper Publication of Unaudited Financial Results for the quarter and nine months ended 31.12.2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c6db41ec-ebcc-4443-8e32-cf2302ddd463.pdf) |
| 11 Apr - Filed Regulation 74(5) compliance certificate for quarter ended 31 March 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 11 Apr - Filed Regulation 74(5) compliance certificate for quarter ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/981cb43e-1ad5-43d8-b767-55f65d458e3d.pdf) |
| — | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5ff37e32-e4b0-4b65-89e0-10495a29ec08.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a1d5cb4e-ffe5-4ea9-9be9-eb6424bfde75.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9ed72602-d6ad-4d06-8716-ca8b580dcff3.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fda8455d-d2b0-43e0-a225-01207b60efa5.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/539287/76905539287.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/539287/72809539287.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/539287/68003539287.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/539287/5392870319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/539287/5392870318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/539287/5392870317.pdf) |
| from bse | [Annual Report 2016 from bse](https://www.bseindia.com/bseplus/AnnualReport/539287/5392870316.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:27:43.609Z.